Efavirenz
Verificar en psychonaut
Efavirenz
Verificar en isomerdesign
Efavirenz
Verificar en pubchem
Efavirenz
Verificar en drugmap
Efavirenz
Verificar en wiki
Data
InChI: InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)
Sinónimos: SR-01000759360-4,Efavirenz & IL-28B,6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one,CHEBI:119486, (-)-Efavirenz,NCGC00159337-02,EFAVIRENZ [MART.], (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one,EFAVIRENZ [WHO-DD],MFCD05662344, Sustiva, (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben, (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, L-743,726,Z2186909878,(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one,(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one,JE6H2O27P8,EFAVIRENZ [INN],DMP266,Z2177953192,Efavirenz & Interleukin 28B,HMS3713M14,EFAVIRENZ COMPONENT OF ATRIPLA,NCGC00159337-12,(S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one,Efavirenz & Interferon lambda-1,Sustiva,ATRIPLA COMPONENT EFAVIRENZ,EFV & Interferon lambda-2,Efavirenz [USP:INN:BAN],EFV & IFNL1,Stocrin,DMP-266,HMS2051J08,AB00639956-08,Efavirenz & Interferon lambda-2,598E524, L-741211, Strocin (TM),EFAVIRENZ [JAN],SR-01000759360, Stocrin (TN),UNII-JE6H2O27P8,(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one,DB00625,NSC-742403,HSDB 7163,Efavirenz- Bio-X,(Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726,(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one,Efavirenz & IFNL2,L-743,726,HY-10572, (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one,F17329,J-520431,Efavirenzum,Efavirenz & Interferon lambda-3,(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,E0997,AC-25006,Efavirenz & IL-29,NSC 742403,DMP 266,DTXSID9046029,EFV & Interleukin 29,2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-,Efavirenz teva,DSSTox_GSID_46029, Sustiva (TN), Stocrin,(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,C08088,MLS001424087,EFAVIRENZUM [WHO-IP LATIN],Efavirenz, (S),EFAVIRENZ [USP MONOGRAPH],(S)-Efavirenz,GTPL11287,Strocin (TM),BCPP000245,Efavirenz (JAN/USP/INN),AB21723,efavirenz,L 743726,CHEMBL223228, (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one,SCHEMBL37762,CAS-154598-52-4,KS-5380,Efavirenz & Poly-lactide-co-glycolide, DMP 266,(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one,NCGC00159337-04,EFAVIRENZ [USAN],AB00639956-06,EFV & IL-28A,EFV & IL-28B,Viraday,Efavirenz solution, 1.0 mg/mL in acetonitrile, certified reference material,A809555,2H-3, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-,(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE, Efavirenz (JAN/INN),(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,Efavirenz,EFV & IFNL3,Efavirenz & IFNL1,HMS3393J08,EN300-219935,Efavirenz & PLGA,EFAVIRENZ [EMA EPAR], Eravirenz,(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,HMS2090N16,EFV, Sustiva (TM),Efavirenz & IFNL3,Sustiva (TN), 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9,Efavirenz & Interleukin 28A,EFAVIRENZ [VANDF],EFAVIRENZ [WHO-IP],SMR000466351,Met-SDF-1.beta. & Efavirenz,D00896,154598-52-4,s4685,EFAVIRENZ [MI],(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one, EFZ,CCG-101011,SR-01000759360-5,ZINC2020233, DMP-266,Efavirenz 100 microg/mL in Acetonitrile,BCP27719,(-)-Efavirenz,EFAVIRENZ [HSDB],Q422645,BIDD:GT0383,Sustiva (TM),EFV & Interleukin 28B, L 743726,Tox21_111582_1,AMY229,(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one,EFV & IL-29,AKOS015894951,(S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE,1ikw,TELURA COMPONENT EFAVIRENZ,Efavirenz & Interleukin 29,NSC742403,EFV & IFNL2,NC00261,DSSTox_RID_81298,EFAVIRENZ [ORANGE BOOK],2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-, Efavirenz, (S)-isomer,L-743726,EFAVIRENZ [USP-RS],DL-535,Efavirenz Ready Made Solution,BC164402,DSSTox_CID_26029, Zoxazin-2-one,Efavirenz, United States Pharmacopeia (USP) Reference Standard,MLS000759465,BCP9000636,Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz,Tox21_111582, Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz, L-743726,1ikv,EFV & Interleukin 28A,(s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one,BDBM2483,(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one,Efavirenz, >=98% (HPLC),EFV & Interferon lambda-3,Eravirenz,EFV & Interferon lambda-1, L-743725, (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,NCGC00271713-05,Efavirenz & IL-28A,(Rac)-Efavirenz, Met-SDF-1.beta. & Efavirenz,NCGC00271713-08,EFV & PLGA, (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,DMP-266; Efavirenz
Estimated data
Solubilidad: -5.093 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 32.4% (prediction based on www.mdpi.com)
